Efficiency of the Ortho VITROS assay for detection of hepatitis C virus-specific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios

Journal of Clinical Microbiology

Volumn 43, Issue 5, 2005, Pages 2477-2480

  Oethinger, Margret ^b   Mayo, Donald R ^a,b   Falcone, JoAnne ^a   Barua, Pankaj K ^a   Griffith, Brigitte P ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ALGORITHM; ANALYTIC METHOD; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CHEMOLUMINESCENCE; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; NONHUMAN; PRIORITY JOURNAL;

CHEMILUMINESCENT MEASUREMENTS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; REPRODUCIBILITY OF RESULTS; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 18544377875     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.5.2477-2480.2005     Document Type: Article

References (12)

1. Bini, E. J. 2003. Hepatitis C in veterans. Curr. Hepatitis Rep. 2:108-115.
2. Centers for Disease Control and Prevention. 2003. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus (anti-HCV). Morb. Mortal. Wkly. Rep. 52(RR-3):1-13.
3. Courouce, A. M., N. Le Marrec, A. Girault, S. Ducamp, and N. Simon. 1994. Anti-hepatitis C virus seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays. Transfusion 34:790-795.
4. Damen, M., H. L. Zaauer, H. T. M. Cuypers, V. Vrielink, C. L. Van Der Poel, H. W. Reesink, and P. N. Lelie. 1995. Reliability of the third generation recombinant immunoblot assay for hepatitis C virus. Transfusion 35:745-749.
5. Dos Santos, V. A., R. S. Azevedo, M. E. Camargo, and V. A. Alves. 1999. Serodiagnosis of hepatitis C virus. Effect of new evaluation of cutoff values for enzyme-linked immunosorbent assay in Brazilian patients. Am. J. Clin. Pathol. 112:418-424.
6. Dufour, D. R., M. Talastas, M. D. A. Fernandez, B. Harris, D. B. Strader, and L. B. Seeff. 2003. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin. Chem. 49:479-486.
7. Dufour, D. R., M. Talastas, M. D. A. Fernandez, and B. Harris. 2003. Chemiluminescence assay improves specificity of hepatitis C antibody detection. Clin. Chem. 49:940-944.
8. Griffith, B. P., J. Falcone, D. Miko, C. K. Y. Fong, P. K. Barua, S. Campbell, and G. Stack. 2003. Hepatitis C virus antibody signal to cut-off ratios predictive of HCV RNA detection: comparison of the Ortho Vitros and EIA assays. Nineteenth Annu. Clin. Virol. Symp., abstr. M48.
9. Ismail, N., G. E. Fish, and M. B. Smith. 2004. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J. Clin. Microbiol. 42:610-617.
10. Pawlotsky, J. M., A. Bastie, C. Pellet, J. Remire, F. Darthuy, L. Wolfe, C. Sayada, J. Duval, and D. Dhumeaux. 1996. Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J. Clin. Microbiol. 34:80-83.
11. Tobler, L. H., G. Tegtmeier, S. L. Stramer, S. Quan, J. Dockter, G. Giachetti, and M. P. Busch. 2000. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays: justification and rational implementation. Transfusion 40:15-24.
12. Vernelen, K., H. Claeys, H. Vernhaert, A. Volclaerts, and C. Vermylen. 1994. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 343:853.